Product

• US 20020193758A1
• Filed: 06/18/2002
• Published: 12/19/2002
• Est. Priority Date: 06/18/2001
• Status: Abandoned Application

• Current Assignee: SCA Hygiene Products AB (Essity AB)
• Original Assignee: SCA Hygiene Products AB (Essity AB)
• Inventors: Sandberg, Stefan
• Application Number:
  US10/173,111
• Publication Number:
  US 20020193758A1
• Time in Patent Office: Days
• US Class Current: 604/304
• CPC Class Codes: A61F 13/47209 having only interlabial part, i.e. with no extralabial parts
• CPC Class Codes: A61F 13/47227 for interlabial use
• CPC Class Codes: A61F 13/8405 Additives, e.g. for odour, disinfectant or pH control
• CPC Class Codes: A61K 9/0036 Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
• CPC Class Codes: A61K 9/70 Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug hollow drug-filled fibres A61K9/0092
• CPC Class Codes: A61K 9/703 characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
• CPC Class Codes: A61L 15/44 Medicaments
• CPC Class Codes: A61L 2300/40 characterised by a specific therapeutic activity or mode of action
• CPC Class Codes: A61L 2300/802 Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Abstract

The present invention provides an absorbent article, selected from the group consisting of a sanitary napkin, a panty liner, and an interlabial menstruation protection device, wherein the article is suitable for administrating a pharmaceutical substance. In one embodiment, the pharmaceutical substance is suitable for treating, mitigating and/or preventing the premenstrual syndrome. The article comprises an absorbent body and has a generally elongated shape. The article has a first surface which is intended to face the wearer, and it has a second surface which is intended to face away from the wearer. The first surface, which is intended to face the wearer, is at least partially covered with a transdermal therapeutic system containing a compound suitable for treating and/or preventing the pre-menstrual syndrome, whereby said compound is transdermally administrated to the wearer when said article is worn.

Claims

1. An absorbent article, selected from the group consisting of a sanitary napkin, a panty liner, and an intralabial menstruation protection device, said article being suitable for administrating a pharmaceutical substance for treating, mitigating and/or preventing the premenstrual syndrome, said article comprising an absorbent body and having a generally elongated shape, having a first surface which is intended to face the wearer, and having a second surface which is intended to face away from the wearer characterised in that the first surface, which is intended to face the wearer, is at least partially covered with a transdermal therapeutic system containing a compound suitable for treating and/or preventing the premenstrual syndrome, whereby said compound is transdermally administrated to the wearer when said article is worn.

2. An absorbent article according to claim 1, characterised in that the article is an interlabial device.

3. An absorbent article according to claim 1, characterised in that the article is a sanitary napkin or a panty liner.

4. An absorbent article according to claim 3, characterised in that the artice has a hump on the surface intended to face the wearer.

5. An absorbent article according to claim 4, characterised in that the transdermal therapeutic system is arranged on the hump.

7. An absorbent article according to anyone of claims 1-5, characterised in that the transdermal therapeutic system comprises one to three matrix layers that containing a pharmaceutical substance that can be used to treat and/or prevent premenstrual syndrome, together with matrix-forming compounds and optionally penetration-enhancing agents.

8. An absorbent article according to claim 7, characterised in that the transdermal therapeutic system also comprises a backing layer joined to the surface of the absorbent article that is intendede to face the wearer.

9. An absorbent article according to claim 8, characterised in that the transdermal therapeutic system is covered by a removable peeling layer.

6. An absorbent article according to anyone of the proceeding claims, characterised in that the transdermal therapeutic system is a ceram, a lotion or an ointment.

10. An absorbent article according to anyone of the preceeding claims, characterised in that the pharmaceutical substance that can be used to treat and/or prevent premenstrual syndrome is chosen from the group of linoleic acid and metabolites, such as gamma-linolenic acid, dihomo-gamma linolenic acid, arachidonic acid, and adrenic acid, alpha-linolenic acid and metabolites, gestagens such as gestodene, levonogestrel, desogestrel, norethisterone, norethistosterone acetate and 3-keto-desogestrel, azaspirones or polycyclic amine derivatives including, among all, buspirone, gepirone, ipsapirone, and tandospirone, ergoline derivatives such as lisuride, bromolisuride, terguride, and proterguride.